BREAST CYTOPATHOLOGY

172 Index
Lung cancer, 138
metastatic, 143, 144
small cell, 144, 149, 249
squamous cell, 149
Lymphoma, 139, 149
differentiated from lactationrelated
breast changes,
46
Hodgkin, 139
metastatic, 149
non-Hodgkin, 138, 140
M
Macrophages
foamy, 10
in fibrocystic changes, 20,
21
mucin-containing, 36, 37
Males, breast cancer/tumors in
gynecomastia, 46–51
intraductal papilloma, 68
myofibroblastoma, 78
of prostatic cancer origin, 143
Malpractice lawsuits, 2–3
Mammography
of fat necrosis, 32
of intraductal papilloma, 68
of invasive ductal carcinoma
not otherwise specified
(NOS), 91
of invasive lobular
carcinoma, 99
of neuroendocrine
carcinoma, 128
of secondary tumors, 138
Mastectomy specimens, breast
ductal lavage findings in,
161–162
Mastitis, 16–17
clinical features of, 16
cytomorphologic
characteristics of, 17
differential diagnoses of, 17,
52, 120
granulomatous, 18, 52
silicone, 29–32
Medullary carcinoma, 113–116
clinical features of, 113
cytomorphologic
characteristics of,
113–115
differential diagnosis of, 116
Melanoma, malignant
metastatic, 138, 143,
147–148, 149
Metaplastic carcinoma, 124–127
clinical features of, 124–125
cytomorphologic
characteristics of,
125–127
differential diagnoses of, 127
chondroid syringoma, 77
chronic subareolar abscess,
18
granular cell tumors, 75
inflammatory
myofibroblastic tumors,
52
pseudoangiomatous
stromal hyperplasia, 54
reactive spindle cell
nodules, 55
Metastatic cancers, 138,
142–151
clinical features of, 142–143
cytomorphologic
characteristics of,
143–150
differential diagnoses of,
150–151
gynecomastia, 50
invasive ductal carcinoma
not otherwise specified
(NOS), 96